Otsuka to Pay More Than $4 Million to Resolve Off-Label Marketing Allegations Involvi... ( WASHINGTON March 27 -- Otsuka Am...)

Otsuka to Pay More Than $4 Million to Resolve Off-Label Marketing Allegations Involving Abilify

Date:3/27/2008

WASHINGTON, March 27 /PRNewswire-USNewswire/ -- Otsuka American Pharmaceutical Inc., the U.S. subsidiary of Japanese pharmaceutical manufacturer Otsuka Pharmaceutical Co., Ltd., has agreed to pay more than $4 million to resolve allegations that it marketed Abilify, an atypical antipsychotic drug, for "off-label" uses, the Justice Department announced today.

Otsuka developed Abilify in Japan and then entered into an agreement with Bristol-Myers Squibb (BMS) to co-promote sales of the drug in the United States. Under the agreement, Otsuka sales representatives worked on sales teams led primarily by BMS sales managers. In September 2007, BMS and the government entered into an agreement resolving allegations that BMS had promoted Abilify for off-label uses.

The Food and Drug Administration (FDA) has approved Abilify to treat adult schizophrenia and bi-polar disorder but has not determined the drug to be safe and effective in the treatment of children and adolescents or in the treatment of geriatric patients suffering from dementia-related psychosis. The FDA has mandated that the package for Abilify carry a "black box" warning concerning its use in the treatment of dementia-related psychosis.

Today's settlement resolves government allegations that, from 2002 through the end of 2005, Otsuka knowingly promoted the sale and use of Abilify for pediatric use and to treat dementia-related psychosis. Otsuka is alleged to have participated in directing its sales force to call on child psychiatrists and other pediatric specialists, with the sales force then urging those physicians and others providers to prescribe Abilify for pediatric patients. Otsuka sales representatives also participated in a specialized long term care sales force that called almost exclusively on nursing homes, where dementia-related psychosis is far more prevalent than schizophrenia or bipolar disorder. Because of the potential market benefit, the long term care sales force
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
2. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
3. Accident Fund Recognizes Clark Construction Co. for 2 Million Hours without a Lost-Time Injury
4. National, State Front Line Caregivers Warn About $64 Million Cut to Medicare Funding for Care of Michigan Seniors
5. Global Med Technologies(R), Inc. Announces the Sale of Approximately 3.3 Million Shares of Global Med Common Stock Held by SingXpress Ltd., an Asian Company, to Five American Institutions
6. Video: Walgreens to Provide $35 Million in Free Health Screenings with The Take Care Health Tour
7. Golub Capital Provides $29.5 Million GOLD Facility in Support of the Recapitalization of ExtruMed
8. Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
9. WPCS Announces $12 Million in New Projects
10. Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
11. New York City Staffing Company Charged With Violating H-1B Program Following U.S. Labor Department Finding Almost $3 Million in Back Wages Due 156 Workers

Post Your Comments:

(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and ... free Community Wellness Fair to educate the public on health ... held on Wednesday, May 22, 2013 from 4:00 pm until ... Old Mallard Creek Road, Charlotte, NC 29262). , ... the Mecklenburg County Department of Social Services are ...

(Date:5/21/2013)... AZ (PRWEB) May 21, 2013 ... and inventors who want to develop their ideas ... summer program. , The university is recruiting ... revolutionary new “formation space” that provides early-stage entrepreneurs ... While AREA48 is open to anyone, ASU is ...

(Date:5/21/2013)... 2013 Diversity Focus, a non-profit organization ... all residents in the Creative Corridor region, is releasing ... a news conference on Thursday, May 23rd at 10:30 ... in 2008. , The survey is a ... support efforts that attract, nurture and retain people of ...

(Date:5/21/2013)... two proteins, thrombospondin-1 and prosaposin, play in discouraging ... a five-amino acid fragment of prosaposin that significantly ... breast and lung cancer. The findings suggest that ... a variety of cancers. , The study ... Children,s Hospital, Vivek Mittal, PhD, at Weill Cornell ...

(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... Vinci surgery robot lawsuit is nearing its conclusion ... According to Bloomberg.com, during closing statements yesterday, an attorney ... dealership, alleging the company wanted to tie sales and ... do all the training to keep control of surgeons, ...

Breaking Medicine News(10 mins):Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4 Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2 Health News:Changing cancer's environment to halt its spread 2 Health News:Changing cancer's environment to halt its spread 3 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4

[0] Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives [0] ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors [0] Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m.[0] Changing cancer's environment to halt its spread [0] Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial

... , ROCHESTER, N.Y., Aug. 12 VirtualScopics, Inc. (Nasdaq: ... announced its financial results for the quarter and six months ended June 30, ... Revenues for the second quarter of 2009 increased 47% to $2.5 ... Gross profit for the second quarter of 2009 increased 96% ...

... NEWARK, N.J., Aug. 12 BioNeutral Group, Inc. ("BioNeutral") (OTC ... that ATS Labs using the EPA required AOAC Sporicidal Test with Ygiene(TM) ... over one million live Clostridium ... time frame - performance which is up to 75 times faster than ...

... With the recent increase in the tobacco tax, many Floridians ... times - do they pay the extra dollar per pack or ... The Florida Quitline (1-877-U-CAN-NOW) is here to help by offering free ... According to Kim Berfield, Deputy Secretary of the Florida Department of ...

... , , , , ... a leading provider of Linux-bas e d ... Systems, a national health care management company, has deployed Arkeia Network Backup. ... Goold has realized dramatic improvements in backup performance and in backup administration. ...

... August 12 Fountain Healthy Aging,Inc. announced on August 12 ... Partners and Oak Resources Limited which provides the Company,with a ... the,agreement, Fountain has the right to draw down from the ... a term of 24 months. The,first tranche investment of $1,000,000 ...

... , WESTFIELD, Ind., Aug. 12 ... company for healthcare providers, announced the successful "Stage 6" designation ... hospital located in Silver City, New Mexico. maxIT assisted the ... IT consultants to support the implementation of several HIS modules. ...

VirtualScopics, Inc. Reports a Record Breaking Quarter BioNeutral's Ygiene(TM) Achieves World's Fastest Kill Time With a 100% Total Spore Eradication Verified In Independent Sporicidal/Sterilant Test The Time To Quit Is Now -- Free NRT Is Available Goold Health Systems Accelerates Backups by 5-times Using Arkeia Network Backup Fountain Healthy Aging Inc Announces $5,000,000 Equity Line Of Credit Investment Secured maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition

(Date:5/21/2013)... 21, 2013 Reportlinker.com announces that ... in its catalogue: ... Optical Coherence Tomography (OCT) ... OBJECTIVES BCC,s ... offer synopsis of the current and future ...

(Date:5/21/2013)... and TARRYTOWN, N.Y. , May ... SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced ... published online the positive Phase 2a study results of ... is an investigational monoclonal antibody targeting the alpha subunit ... signaling of both IL-4 and IL-13, drivers of Th2 ...

(Date:5/21/2013)... 21, 2013 Healthcare organizations expanding into emerging markets ... , India and ... no shortcuts. This is proving particularly challenging, considering the ... must change the dialogue around BRIC, as it is ... and building regional partnerships to build a sustainable business. ...

Breaking Medicine Technology:Global Markets and Technologies for Optical Coherence Tomography (OCT) 2 Global Markets and Technologies for Optical Coherence Tomography (OCT) 3 Global Markets and Technologies for Optical Coherence Tomography (OCT) 4 Global Markets and Technologies for Optical Coherence Tomography (OCT) 5 Global Markets and Technologies for Optical Coherence Tomography (OCT) 6 Global Markets and Technologies for Optical Coherence Tomography (OCT) 7 Global Markets and Technologies for Optical Coherence Tomography (OCT) 8 Global Markets and Technologies for Optical Coherence Tomography (OCT) 9 Global Markets and Technologies for Optical Coherence Tomography (OCT) 10 Global Markets and Technologies for Optical Coherence Tomography (OCT) 11 Global Markets and Technologies for Optical Coherence Tomography (OCT) 12 Global Markets and Technologies for Optical Coherence Tomography (OCT) 13 Global Markets and Technologies for Optical Coherence Tomography (OCT) 14 Global Markets and Technologies for Optical Coherence Tomography (OCT) 15 Global Markets and Technologies for Optical Coherence Tomography (OCT) 16 Global Markets and Technologies for Optical Coherence Tomography (OCT) 17 Global Markets and Technologies for Optical Coherence Tomography (OCT) 18 Global Markets and Technologies for Optical Coherence Tomography (OCT) 19 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7 Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2 Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3 Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4

[0] Global Markets and Technologies for Optical Coherence Tomography (OCT)[0] Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine [0] Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets

... NEW YORK, Sept. 28 Delcath Systems, Inc. (Nasdaq: ... the William Blair Emerging Growth Stock Conference on Tuesday, October ... Mr. David McDonald, Chief Financial Officer, will provide an overview ... Attendance at this conference is by invitation only. Delcath ...

... BOTHELL, Wash., Sept. 27 SCOLR Pharma, Inc. (NYSE ... Johnson has been appointed as the Chairman of its ... remain a member of the Board. ... of Matrixx Initiatives, Inc. Under Johnson,s leadership, Matrixx successfully ...

Cached Medicine Technology:Delcath to Present at the William Blair Emerging Growth Stock Conference 2 SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director 2 SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director 3

Delcath to Present at the William Blair Emerging Growth Stock Conference SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director

Custom Pediatric Nebulizer Assembly W/Tubing...

... Patients over the age of 3 can choose ... STAR®. The same design principle applies to both:, ... and minimize aerosol output when the patient exhales ... optimum size to leave the nebulizer. The result ...

... medication nebulizer achieves optimum lung penetration for ... range is 1.04-1.10 µ at 6-8 LPM. ... outlet., ,As the world leader in ... the assurance of proven technology by offering ...

... Portex® medication nebulizers offer a spill-proof design ... to a 45° angle. All medical nebulizers ... wide variety of configurations are available., ... , ,Portex® medication nebulizers feature consistently ...

Medicine Products:

Pediatric Custom Nebulizers PARI LC STAR® Reusable Nebulizer Raindrop® Medication Nebulizer - Pediatric Aerosol Mask & Tubing 007767 Medication Nebulizer Kit